Literature DB >> 2433767

Neocortical transplants in the mammalian brain lack a blood-brain barrier to macromolecules.

J M Rosenstein.   

Abstract

In order to determine whether the blood-brain barrier was present in transplants of central nervous tissue, fetal neocortex, which already possesses blood-brain and blood-cerebrospinal fluid barriers to protein, was grafted into the undamaged fourth ventricle or directly into the neocortex of recipient rats. Horseradish peroxidase or a conjugated human immunoglobulin G-peroxidase molecule was systemically administered into the host. These proteins were detected within the cortical transplants within 2 minutes regardless of the age of the donor or postoperative time. At later times these compounds, which normally do not cross the blood-brain barrier, inundated the grafts and adjacent host brain and also entered the cerebrospinal fluid. Endogenous serum albumin detected immunocytochemically in untreated hosts had a comparable although less extensive distribution. Thus, transplants of fetal central nervous tissue have permanent barrier dysfunction, probably due to microvascular changes, and are not integrated physiologically within the host. Blood-borne compounds, either systemically administered or naturally occurring, which should never contact normal brain tissue, have direct access to these transplants and might affect neuronal function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433767     DOI: 10.1126/science.2433767

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Neural induction of the blood-brain barrier: still an enigma.

Authors:  H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Neural transplantation for Parkinson's disease.

Authors:  I Date; T Ohmoto
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

Review 3.  Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Authors:  R D Broadwell
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 4.  Ultracytochemical study of capillary Ca2+-ATPase activity in brain edema.

Authors:  K Kawai; H Takahashi; F Ikuta
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  The neurosurgeon and the blood-brain barrier. A survey.

Authors:  K G Go
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

6.  Morphological aspects of the vascularization in intraventricular neural transplants from embryo to embryo.

Authors:  L Roncali; D Virgintino; P Coltey; M Bertossi; M Errede; D Ribatti; B Nico; L Mancini; S Sorino; A Riva
Journal:  Anat Embryol (Berl)       Date:  1996-03

7.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

8.  Influence of nembutal on the impulse activity of cells of embryonal nervous tissue transplanted into the rat brain.

Authors:  V V Senatorov; G P Obukhova; V L Silakov
Journal:  Neurosci Behav Physiol       Date:  1991 Jul-Aug

9.  Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier.

Authors:  P Brundin; H Widner; O G Nilsson; R E Strecker; A Björklund
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 10.  Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.

Authors:  H Widner; P Brundin
Journal:  Brain Res       Date:  1988-11       Impact factor: 3.252

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.